PI3K/Akt and HIF‑1 signaling pathway in hypoxia‑ischemia (Review)
- Authors:
- Zhen Zhang
- Li Yao
- Jinhua Yang
- Zhenkang Wang
- Gang Du
-
Affiliations: Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Science, Guangzhou, Guangdong 510100, P.R. China, Department of Bioinformatics, Guangzhou GenCoding Lab, Guangzhou, Guangdong 510670, P.R. China, Department of Cardiovascular Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China - Published online on: August 9, 2018 https://doi.org/10.3892/mmr.2018.9375
- Pages: 3547-3554
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Movsas TZ, Weiner RL, Greenberg MB, Holtzman DM and Galindo R: Pretreatment with human chorionic gonadotropin protects the neonatal brain against the effects of hypoxic-ischemic injury. Front Pediatr. 5:2322017. View Article : Google Scholar : PubMed/NCBI | |
|
Ferriero DM: Neonatal brain injury. N Engl J Med. 351:1985–1995. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Adluri RS, Thirunavukkarasu M, Zhan L, Akita Y, Samuel SM, Otani H, Ho YS, Maulik G and Maulik N: Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: A study using thioredoxin 1 transgenic mice. J Mol Cell Cardiol. 50:239–247. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Greenberg DA and Jin K: From angiogenesis to neuropathology. Nature. 438:954–959. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Yellon DM and Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Eltzschig HK and Eckle T: Ischemia and reperfusion-from mechanism to translation. Nat Med. 17:1391–1401. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Li L, Qu Y, Mao M, Xiong Y and Mu D: The involvement of phosphoinositid 3-kinase/Akt pathway in the activation of hypoxia-inducible factor-1alpha in the developing rat brain after hypoxia-ischemia. Brain Res. 1197:152–158. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Fruman DA, Meyers RE and Cantley LC: Phosphoinositide kinases. Annu Rev Biochem. 67:481–507. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Pawson T and Nash P: Protein-protein interactions define specificity in signal transduction. Genes Dev. 14:1027–1047. 2000.PubMed/NCBI | |
|
Zhang F, Ding T, Yu L, Zhong Y, Dai H and Yan M: Dexmedetomidine protects against oxygen-glucose deprivation-induced injury through the I2 imidazoline receptor-PI3K/AKT pathway in rat C6 glioma cells. J Pharm Pharmacol. 64:120–127. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ciuffreda L, Falcone I, Incani UC, Del Curatolo A, Conciatori F, Matteoni S, Vari S, Vaccaro V, Cognetti F and Milella M: PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting. Adv Biol Regul. 56:66–80. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cantley LC: The phosphoinositide 3-kinase pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Han JQ, Yu KY and He M: Effects of puerarin on the neurocyte apoptosis and p-Akt (Ser473) expressions in rats with cerebral ischemia/reperfusion injury. Zhongguo Zhong Xi Yi Jie He Za Zhi. 32:1069–1072. 2012.(In Chinese). PubMed/NCBI | |
|
Liu BN, Han BX and Liu F: Neuroprotective effect of pAkt and HIF-1α on ischemia rats. Asian Pac J Trop Med. 7:221–225. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li D, Qu Y, Mao M, Zhang X, Li J, Ferriero D and Mu D: Involvement of the PTEN-AKT-FOXO3a pathway in neuronal apoptosis in developing rat brain after hypoxia-ischemia. J Cereb Blood Flow Metab. 29:1903–1913. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Wang Y, Ye J, Lu X, Cheng Y, Xiang L, Chen L, Feng W, Shi H, Yu X, et al: bFGF attenuates endoplasmic reticulum stress and mitochondrial injury on myocardial ischaemia/reperfusion via activation of PI3K/Akt/ERK1/2 pathway. J Cell Mol Med. 19:595–607. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Liu MH, Li GH, Peng LJ, Qu SL, Zhang Y, Peng J, Luo XY, Hu HJ, Ren Z, Liu Y, et al: PI3K/Akt/FoxO3a signaling mediates cardioprotection of FGF-2 against hydrogen peroxide-induced apoptosis in H9c2 cells. Mol Cell Biochem. 414:57–66. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Correia SC, Cardoso S, Santos RX, Carvalho C, Santos MS, Perry G, Smith MA and Moreira PI: New insights into the mechanisms of mitochondrial preconditioning-triggered neuroprotection. Curr Pharm Des. 17:3381–3389. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW and Semenza GL: Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics. Cancer Res 60: 1541–1545, 2000. Cancer Res 60: 1541–1545, 2000. 60: 1541–1545, 2000:1541-1545, 2000–1545, 2000. 2000. | |
|
Wang Z, Zhang H, Xu X, Shi H, Yu X, Wang X, Yan Y, Fu X, Hu H, Li X and Xiao J: bFGF inhibits ER stress induced by ischemic oxidative injury via activation of the PI3K/Akt and ERK1/2 pathways. Toxicol Lett. 212:137–146. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kunze R, Zhou W, Veltkamp R, Wielockx B, Breier G and Marti HH: Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia. Stroke. 43:2748–2756. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Semenza GL: Hypoxia-inducible factors in physiology and medicine. Cell. 148:399–408. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Jain T, Nikolopoulou EA, Xu Q and Qu A: Hypoxia inducible factor as a therapeutic target for atherosclerosis. Pharmacol Ther. 183:22–33. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao Y, Peng H, Hong C, Chen Z, Deng X, Wang A, Yang F, Yang L, Chen C and Qin X: PDGF promotes the warburg effect in pulmonary arterial smooth muscle cells via activation of the PI3K/AKT/mTOR/HIF-1α signaling pathway. Cell Physiol Biochem. 42:1603–1613. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Laughner E, Taghavi P, Chiles K, Mahon PC and Semenza GL: HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol. 21:3995–4004. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Yang XM, Wang YS, Zhang J, Li Y, Xu JF, Zhu J, Zhao W, Chu DK and Wiedemann P: Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization. Invest Ophthalmol Vis Sci. 50:1873–1879. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Karar J, Cerniglia GJ, Lindsten T, Koumenis C and Maity A: Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translation and increases cell death under hypoxia. Cancer Biol Ther. 13:1102–1111. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
van den Beucken T, Koritzinsky M and Wouters BG: Translational control of gene expression during hypoxia. Cancer Biol Ther. 5:749–755. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Hudson CC, Liu M, Chiang GG, Otterness DM, Loomis DC, Kaper F, Giaccia AJ and Abraham RT: Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol. 22:7004–7014. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Ivan M and Kaelin WG Jr: The von Hippel-Lindau tumor suppressor protein. Curr Opin Genet Dev. 11:27–34. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Bai S, Datta J, Jacob ST and Ghoshal K: Treatment of PC12 cells with nerve growth factor induces proteasomal degradation of T-cadherin that requires tyrosine phosphorylation of its cadherin domain. J Biol Chem. 282:27171–27180. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Dimova EY, Michiels C and Kietzmann T: Kinases as upstream regulators of the HIF system: their emerging potential as anti-cancer drug targets. Curr Pharm Des. 15:3867–3877. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Yao HC, Zhou M, Zhou YH, Wang LH, Zhang DY, Han QF, Liu T, Wu L, Tian KL and Zhang M: Intravenous high mobility group box 1 upregulates the expression of HIF-1α in the myocardium via a protein kinase B-dependent pathway in rats following acute myocardial ischemia. Mol Med Rep. 13:1211–1219. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zaman K, Ryu H, Hall D, O'Donovan K, Lin KI, Miller MP, Marquis JC, Baraban JM, Semenza GL and Ratan RR: Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21 (waf1/cip1), and erythropoietin. J Neurosci 19: 9821–9830, 1999. J Neurosci 19: 9821–9830, 1999. 19: 9821–9830, 1999:9821-9830, 1999–9830, 1999. 1999. | |
|
Hamrick SE, McQuillen PS, Jiang X, Mu D, Madan A and Ferriero DM: A role for hypoxia-inducible factor-1alpha in desferoxamine neuroprotection. Neurosci Lett. 379:96–100. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Sharp FR and Bernaudin M: HIF1 and oxygen sensing in the brain. Nat Rev Neurosci. 5:437–448. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Semenza GL: Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med. 54:17–28. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Blanco Pampin J, Garcia Rivero SA, Otero Cepeda XL, Vázquez Boquete A, Forteza Vila J and Hinojal Fonseca R: Immunohistochemical expression of HIF-1alpha in response to early myocardial ischemia. J Forensic Sci. 51:120–124. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Shi H: Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke. Curr Med Chem. 16:4593–4600. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG and Semenza GL: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 105:659–669. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Minet E, Michel G, Remacle J and Michiels C: Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis (review). Int J Mol Med. 5:253–259. 2000.PubMed/NCBI | |
|
Semenza GL: Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol. 19:12–16. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Adekola K, Rosen ST and Shanmugam M: Glucose transporters in cancer metabolism. Curr Opin Oncol. 24:650–654. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Semenza GL: Hypoxia-inducible factor 1: Regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta. 1813:1263–1268. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kim JW, Tchernyshyov I, Semenza GL and Dang CV: HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3:177–185. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Simon MC: Coming up for air: HIF-1 and mitochondrial oxygen consumption. Cell Metab. 3:150–151. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Chen C, Pore N, Behrooz A, Ismail-Beigi F and Maity A: Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem. 276:9519–9525. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Lu H, Forbes RA and Verma A: Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem. 277:23111–23115. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Semenza GL: HIF-1 mediates the Warburg effect in clear cell renal carcinoma. J Bioenerg Biomembr. 39:231–234. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Maxwell PH, Pugh CW and Ratcliffe PJ: Activation of the HIF pathway in cancer. Curr Opin Genet Dev. 11:293–299. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Semenza GL: HIF-1: Upstream and downstream of cancer metabolism. Curr Opin Genet Dev. 20:51–56. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Nagy MA: HIF-1 is the commander of gateways to cancer. J Cancer Sei Ther. 3:35–40. 2011. | |
|
Courtnay R, Ngo DC, Malik N, Ververis K, Tortorella SM and Karagiannis TC: Cancer metabolism and the Warburg effect: The role of HIF-1 and PI3K. Mol Biol Rep. 42:841–851. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Dang CV: Links between metabolism and cancer. Genes Dev. 26:877–890. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Martini M, De Santis MC, Braccini L, Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: an updated review. Ann Med. 46:372–383. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC and Harris AL; Tumour Angiogenesis Research Group, : Lactate dehydrogenase 5 expression in operable colorectal cancer: Strong association with survival and activated vascular endothelial growth factor pathway-a report of the Tumour Angiogenesis Research Group. J Clin Oncol. 24:4301–4308. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Solaini G, Baracca A, Lenaz G and Sgarbi G: Hypoxia and mitochondrial oxidative metabolism. Biochim Biophys Acta. 1797:1171–1177. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Samuel SM, Akita Y, Paul D, Thirunavukkarasu M, Zhan L, Sudhakaran PR, Li C and Maulik N: Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats. Diabetes. 59:51–60. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Bai WW, Xing YF, Wang B, Lu XT, Wang YB, Sun YY, Liu XQ, Guo T and Zhao YX: Tongxinluo improves cardiac function and ameliorates ventricular remodeling in mice model of myocardial infarction through enhancing angiogenesis. Evid Based Complement Alternat Med 2013. 8132472013. | |
|
Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, Chen X, Michael A, Haq S, Nuedling S, Grohe C, et al: 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res. 95:692–699. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
He Z, Opland DM, Way KJ, Ueki K, Bodyak N, Kang PM, Izumo S, Kulkarni RN, Wang B, Liao R, et al: Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia. Arterioscler Thromb Vasc Biol. 26:787–793. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Graupera M, Guillermet-Guibert J, Foukas LC, Phng LK, Cain RJ, Salpekar A, Pearce W, Meek S, Millan J, Cutillas PR, et al: Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration. Nature. 453:662–666. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sumida A, Horiba M, Ishiguro H, Takenaka H, Ueda N, Ooboshi H, Opthof T, Kadomatsu K and Kodama I: Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction. Cardiovasc Res. 86:113–121. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Dutta PR and Maity A: Cellular responses to EGFR inhibitors and their relevance to cancer therapy. Cancer Lett. 254:165–177. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Chen JX and Meyrick B: Hypoxia increases Hsp90 binding to eNOS via PI3K-Akt in porcine coronary artery endothelium. Lab Invest. 84:182–190. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Hirota K and Semenza GL: Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol. 59:15–26. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW and Thistlethwaite PA: Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol. 46:2116–2124. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Khan M, Varadharaj S, Ganesan LP, Shobha JC, Naidu MU, Parinandi NL, Tridandapani S, Kutala VK and Kuppusamy P: C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling. Am J Physiol Heart Circ Physiol. 290:H2136–H2145. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tian T, Nan KJ, Wang SH, Liang X, Lu CX, Guo H, Wang WJ and Ruan ZP: PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells. Carcinogenesis. 31:1211–1219. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD and Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 16:4604–4613. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS and Gallick GE: HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene. 24:3110–3120. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Guo S, Miyake M, Liu KJ and Shi H: Specific inhibition of hypoxia inducible factor 1 exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment. J Neurochem. 108:1309–1321. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z and Si LY: Hypoxia-inducible factor-1α and vascular endothelial growth factor in the cardioprotective effects of intermittent hypoxia in rats. Ups J Med Sci. 118:65–74. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 394:485–490. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Halterman MW and Federoff HJ: HIF-1alpha and p53 promote hypoxia-induced delayed neuronal death in models of CNS ischemia. Exp Neurol. 159:65–72. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Halterman MW, Miller CC and Federoff HJ: Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci. 19:6818–6824. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Chen C, Hu Q, Yan J, Lei J, Qin L, Shi X, Luan L, Yang L, Wang K, Han J, et al: Multiple effects of 2ME2 and D609 on the cortical expression of HIF-1alpha and apoptotic genes in a middle cerebral artery occlusion-induced focal ischemia rat model. J Neurochem. 102:1831–1841. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, Gonzalez FJ and Semenza GL: Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem. 283:10892–10903. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y, Chen X, Zhang X, Shen X, Wang M, Wang X, Liu WC, Liu CF, Liu J, Liu W and Jin X: β2-adrenergic receptor-mediated HIF-1α upregulation mediates blood brain barrier damage in acute cerebral ischemia. Front Mol Neurosci. 10:2572017. View Article : Google Scholar : PubMed/NCBI | |
|
Wong CC, Gilkes DM, Zhang H, Chen J, Wei H, Chaturvedi P, Fraley SI, Wong CM, Khoo US, Ng IO, et al: Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proc Natl Acad Sci USA. 108:pp. 16369–16374. 2011; View Article : Google Scholar : PubMed/NCBI | |
|
Wong CC, Zhang H, Gilkes DM, Chen J, Wei H, Chaturvedi P, Hubbi ME and Semenza GL: Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis. J Mol Med (Berl). 90:803–815. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Liu ZJ, Semenza GL and Zhang HF: Hypoxia-inducible factor 1 and breast cancer metastasis. J Zhejiang Univ Sci B. 16:32–43. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS and Chavez JC: Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci. 27:6320–6332. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Helton R, Cui J, Scheel JR, Ellison JA, Ames C, Gibson C, Blouw B, Ouyang L, Dragatsis I, Zeitlin S, et al: Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci. 25:4099–4107. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Filippi I, Morena E, Aldinucci C, Carraro F, Sozzani S and Naldini A: Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1α and PI3K/Akt pathway. J Cell Physiol. 229:2067–2076. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Hu X, Wei L, Taylor TM, Wei J, Zhou X, Wang JA and Yu SP: Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation. Am J Physiol Cell Physiol. 301:C362–C372. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA and Wei L: Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg. 135:799–808. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Jian KT, Shi Y, Zhang Y, Mao YM, Liu JS and Xue FL: Time course effect of hypoxia on bone marrow-derived endothelial progenitor cells and their effects on left ventricular function after transplanted into acute myocardial ischemia rat. Eur Rev Med Pharmacol Sci. 19:1043–1054. 2015.PubMed/NCBI | |
|
Ginouvès A, Ilc K, Macias N, Pouysségur J and Berra E: PHDs overactivation during chronic hypoxia ‘desensitizes’ HIFalpha and protects cells from necrosis. Proc Natl Acad Sci USA. 105:pp. 4745–4750. 2008; View Article : Google Scholar : PubMed/NCBI | |
|
Poitz DM, Augstein A, Hesse K, Christoph M, Ibrahim K, Braun-Dullaeus RC, Strasser RH and Schmeißer A: Regulation of the HIF-system in human macrophages-differential regulation of HIF-α subunits under sustained hypoxia. Mol Immunol. 57:226–235. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Higgins RD, Raju T, Edwards AD, Azzopardi DV, Bose CL, Clark RH, Ferriero DM, Guillet R, Gunn AJ, Hagberg H, et al: Hypothermia and other treatment options for neonatal encephalopathy: An executive summary of the Eunice Kennedy Shriver NICHD workshop. J Pediatr. 159:851–858.e1. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Shankaran S, Pappas A, McDonald SA, Vohr BR, Hintz SR, Yolton K, Gustafson KE, Leach TM, Green C, Bara R, et al: Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med. 366:2085–2092. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Huang J, Zhang L, Qu Y, Zhou Y, Zhu J, Li Y, Zhu T, Zhao F, Tang J and Mu D: Histone acetylation of oligodendrocytes protects against white matter injury induced by inflammation and hypoxia-ischemia through activation of BDNF-TrkB signaling pathway in neonatal rats. Brain Res. 1688:33–46. 2018. View Article : Google Scholar : PubMed/NCBI |
